Global Congress on Pharma and Pharmaceutical Science

Jul 11-12, 2022

|

Orlando, United States of America



About Conference: The most anticipated pharma event in the world and you're invited to attend ''Global Congress on pharma and pharmaceutical science'' scheduled during July 11 ,12 2022 Orlando,United states of America which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. This strategic conference will provide in-depth presentations and interactive sessions, for the possibility to network with like-minded professionals and discuss how to overcome the current challenges in  Pharmaceutical product synthesis and product development. The focus this year will be on the latest advancements, research and development to inspect the challenges in Pharmaceutical Sciences, Clinical Research and related areas. Pharma Congress 2022 is a specially designed cluster of all European Pharma conferences. The main theme of this Pharma conference is ''Looming technologies in pharmaceutical formulation and drug delivery'' which covers a wide range of critically important sessions.

At Pharma Congress meet your target audiences from around the world focused on learning about Pharma regulations, licenses, and approvals. This conference would be your single best opportunity to reach the largest assemblage of participants from the Pharma field.

2022 Highlights:

300+ Participation (70 Industry: 30 Academia)

10+ Keynote Speakers

50+ Plenary Speakers

20+ Exhibitors

14 Innovative Educational Sessions

5+ Workshops

B2B Meetings

Motives to attend:

This year, we will have more senior speakers, who will be joining us from pharmaceutical giants. They're coming to share their experience with us and ensure you can maximize your knowledge.

Get ahead of the competition: Gather fresh intuitions from key speakers to help make restored decisions on doing business in Pharma

Meet & Connect with Senior Stakeholders from the global Pharma network

Content your way: Access a variety of technical and commercial tracks across the entire supply chain, or choose the one track that is most relevant to your business

Save months of research: Don’t spend eras reading whitepapers, come and hear from the decision makers themselves on the latest trends, challenges and opportunities at the forefront of the industry

A Unique Opportunity for Advertisers and Sponsors at this International event

Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Over 50+ organizations and international pavilions will be exhibiting at the Pharmaceutical Sciences 2022 conference.  Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

Target Audience:

Directors, CEO’s of Organizations

Business Development Managers

Chief Scientific Officers

R&D Researchers from Pharma Industries

Professors, Associate Professors, Assistant Professors

PhD Scholars

Patent Attorneys

Investment Analysts

Association, Association presidents and professionals

Noble laureates in Health Care and Medicine

Bio instruments Professionals

Bio-informatics Professionals

Software development companies

Research Institutes and members

Supply Chain companies

Manufacturing Companies

CRO and DATA management Companies

Training Institutes

Business Entrepreneurs

Young Scientist Benefits

Our conferences provide best Platform for your research through oral presentations.

Share the ideas with both eminent researchers and mentors.

Young Scientist Award reorganization certificate and memento to the winners

Young Scientists will get appropriate and timely information by this Forum.

Platform for collaboration among young researchers for better development

Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Conference Highlights

Track 1: Digital Pharma

Some of the people believes that digital capabilities are not only critical to Pharmaceutical companies ability to improve the way they roll out new products, but to increasing the Pharmaceutical industry’s contribution to health care by enabling it to provide innovative services to improve patients’ outcomes. In order to increase the perceived value of Pharma within the health care system, the industry is striving to respond to the needs of all stakeholders: health care professionals, patients and payers. In the meantime, the culture of Pharmaceutical companies is shifting from one of separate departments working vertically to one that is cross functional.

Related Societies:

Societies in the USA: Industry Pharmacists Organization | American Pharmacists Association | American Association of Pharmaceutical Scientists (AAPS) |American Statistical Association | Controlled Release Society | Society for Biomaterials | American Chemical Society |American Coatings Association | Parenteral Drug Association | American Association of Pharmaceutical Scientists (AAPS) | Parenteral Drug Association (PDA) | The International Society of Biopharmaceutical Statistics.

Societies in Europe: European Biopharmaceutical Enterprises | The Danish Society for Biopharmaceutical Statistics | European Society for Biomaterials | Royal Pharmaceutical Society of Great Britain | Turkish Pharmacists Association

Societies in Asia and Pacific: Chinese Biopharmaceutical Association | Pharmaceutical Society of Australia | Pharmacy Guild of Australia | Chinese American Biopharmaceutical Society

Track 2: R&D Advancement: Road to New Medicines

Big pharmaceutical companies develop new business models to cope with the innovation crisis (patent loss, drying up of pipelines) and to improve their productivity in R&D and innovation. These pressures led big players to transform or reinvent their business models to sustain value creation from R&D and innovation. However, to our knowledge, there is still a lack of understanding regarding the “strategic alignment” of these organizational changes and on how they are perceived by organizational members.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 3: Clinical Pharmacy and Therapeutics

Drug absorption is set by the drug’s chemistry properties, formulation, and route of administration. Dosage forms (e.g. tablets, capsules, solutions), consisting of the drug and alternative ingredients, square measure developed to lean by numerous routes (e.g. oral, buccal, sublingual, rectal, parenteral, topical, inhalational). In spite of the route of administration, medicine should be in answer to be absorbed.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 4: Pharmaceutical sciences

The pharmaceutical sciences combine broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease. At the many of institutes internationally recognized faculty contribute to the field through inquiry into the underlying mechanisms of drug interactions with the human body and development of advanced synthetic or biologically-derived materials that can modulate these interactions in pursuit of better and safer therapies and drug products.

Related Societies:

Societies in USA: American Society of Pharmacognosy (ASP) | Phytochemical Society of North America (PSNA) | The Herb Society of America | American Herbal Products Association (AHPA)

Societies in Europe: Phytochemical Society of Europe (PSE) | Society for Medicinal Plant and Natural Product Research | European Herbal and Traditional Medicines Association (EHTPA)

Societies in Asia and Pacific: The Asian Society of Pharmacognosy (ASP) | Society of Pharmacognosy, Malaysian Natural Product Society (MNPS) | The Japanese Society of Pharmacognosy | Australian Society of Plant Scientists

Track 5: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signalling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU), Pharmaceutical Society of Ireland,

Track 6: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment.

Related Societies:

Societies in the USA: American College of Clinical Pharmacology | American Society for Clinical Pharmacology and Therapeutics | American Neurological Association (ANA) | American Society of Neuroimaging | American Board of Psychiatry and Neurology (ABPN) | American Academy of Neurology (AAN)

Societies in Europe: The Federation of European Pharmacological Societies | The European Association for Clinical Pharmacology and Therapeutics (EACPT) |  The European Behavioural Pharmacology Society (EBPS) | British Pharmacological Society

Societies in Asia and Pacific: Korean Society of Pharmacology | Malaysian Society of Pharmacology and Physiology (MSPP) |  Pharmacological Society of Taiwan | Japanese Pharmacological Society

Track 7: Globalized Pharma Sector

Globalized Pharma Sector is based on gaining information on changing structure of competition and increased competitiveness,  lack of brand new products, despite increased investments into R&D (Research& Development) activities, increased importance of regulatory issues (registrations, intellectual propertyrights,litigations), fast consolidation and concentration of the world  Pharmaceutical industry can be known as the Globalized Pharma Sector

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU), Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society.

Track 8: Drug Discovery

In the fields of medicine, biotechnology and Pharmacology, drug discovery is the process by which new candidate medications are discovered. Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy or potency,  metabolic stability  (to increase the half-life),  and oral bioavailability.

Related Societies:

Societies in the USA: Accreditation Council for Pharmacy Education | American Institute of the History of Pharmacy | American Society of Health-System Pharmacists | American Society of Consultant Pharmacists(ASCP)

Societies in Europe: European Medicines Agency | Federal Agency for Medicines and Health Products (FAGG) | Danish Health and Medicines Authority (SST) | Bulgarian Drug Agency (BDA) | Federal Institute for Drugs and Medical Devices (BfArM) | National Organization for Medicines (EOF)

Societies in Asia and Pacific: China Food and Drug Administration (CFDA) | Drug Office - Department of Health | Pharmaceuticals and Medical Devices Agency (PMDA) | Ministry of Food and Drug Safety (MFDS) | Pharmacy and Drug Control

Track 9: Drug Development

Drug development focusses on launch of new Pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED

Track 10: Pharmaceutical Engineering

Pharmaceutical engineering deals with Pharmaceutical Science and technology that involves development and manufacturing of products, processes, and components in the Pharmaceuticals industry (i.e. drugs & biologics). While developing Pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "Pharmaceutical engineering" has only emerged recently as a distinct engineering discipline.

Related Societies:

Societies in the USA: American Institute of Chemists | American Society for Mass Spectrometry | American Association for Clinical Chemistry | American Crystallographic Association | American Society for Biochemistry and Molecular Biology | Brazilian Chemical Association

Societies in Europe: European Association for Chemical and Molecular Sciences | European Association of Employed Community Pharmacists in Europe | European Pharmaceutical Union | Estonian Chemical Society

Societies in Asia and Pacific: Chemical Research Society of India | Chemical Society of Thailand | Chemical Society of the South Pacific | Chemical Society of Turkey | Chinese Chemical Society | Chinese-American Chemical Society

Track 11: Advances in Pharmaceutical Packaging

Packaging plays an important role in providing protection, presentation, convenience, identification information, and compliance of a product during storage, transportation, display and until the product is safely consumed. Packaging may be considered as a system by which the product safely reaches from producer to consumer. The track mainly focuses on recent advances in packaging technology and packaging material. Many types of symbols for package labelling should be nationally and internationally standardized. Packaging symbols represent product certifications, trademarks, proof of purchase .

Related Societies:

European Federation of Pharmaceutical Industries and Associations (EFPIA) Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 12: Purpose and Principles of GMP

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.

Related Societies:

Societies in the USA: American Coatings Association | Parenteral Drug Association (PDA) | American Association of Pharmaceutical Scientists (AAPS) | Consumer Healthcare Products Association | American Urological Association (AUA) | Pharmacy Society of Wisconsin (PSW)

Societies in Europe: Pharmaceutical Society of New Zealand Incorporated (PSNZI) | Royal Pharmaceutical Society (RPS) | Association of British Pharmaceutical Industry (ABPI)

Societies in Asia and Pacific: Bangladesh Pharmaceutical Society (BPS) | Society for Pharmaceutical Dissolution Science (SPDC) | Pharmaceutical and Bioscience Society (PBS)

Track 13: Pharmaceutical Supply Chain Optimization

Supply chain management (SCM) is the integration of key business processes across the supply chain for the purpose of creating value for customers and stakeholders. Indeed, supply chain management integrates supply and demand within and across companies in an efficient business model. The Council of Supply Chain Management Professionals defines supply chain management as planning and management of all activities involved in sourcing, procurement, conversion and all logistics activities. There are various aspects of optimizing in the supply chain; eliminating bottlenecks, balancing between lowest material cost and transportation, optimizing manufacturing flow, maintaining the right mix and location of factories and warehouses, vehicle routing analysis, dynamic programming and efficient use of capacities, inventories, and labours are of main aspects of supply chain optimization.

Related Societies:

Societies in the USA: Controlled Release Society |  Society for Biomaterials | American Chemical Society | American Coatings Association | Parenteral Drug Association | American Association of Pharmaceutical Scientists (AAPS)

Societies in Europe: The British Society for Nanomedicine, | European Society for Biomaterials | Royal Pharmaceutical Society of Great Britain | Turkish Pharmacists Association

Societies in Asia and Pacific: Pharmaceutical Society of Korea | Pharmaceutical Society of Australia | Pharmacy Guild of Australia

Track 14: Pharmaceutical Process Validation

Pharmaceutical Process Validation is the most important and recognized parameters of CGMPs. Quality cannot be adequately assured by in-process and finished inspections and testing but it should be built in to the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. The requirement of process validation appears of the quality system (QS) regulation. The goal of a quality system is to consistently produce products that are fit for their intended use.

Related Societies:

Societies in the USA: American Statistical Association | Controlled Release Society | Society for Biomaterials |  American Chemical Society | American Coatings Association | Parenteral Drug Association | American Association of Pharmaceutical Scientists (AAPShttps://pharmaconference.pharmaceuticalconferences.com/abstract-submission.php) | Parenteral Drug Association (PDA) | The International Society of Biopharmaceutical Statistics.

Societies in Europe: European Biopharmaceutical Enterprises | The Danish Society for Biopharmaceutical Statistics | European Society for Biomaterials | Royal Pharmaceutical Society of Great Britain | Turkish Pharmacists Association

Societies in Asia and Pacific: Chinese Biopharmaceutical Association | Pharmaceutical Society of Australia |  Pharmacy Guild of Australia | Chinese American Biopharmaceutical Society.

Track 15: Regulatory Requirements for Pharmaceuticals

The area unit variety of motives for extending the merchandise development outside of the mature, developed economies (e.g. the EU and therefore the US) and most of them have faith in the high population and market potential of rising markets. FDA guidance for clinical investigations and Pharmaceutical development goes a lot of and a lot of international within the direction of rising markets that tend to supply solutions for the patient achievement and overall development prices and timelines.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 16: Medico Marketing

Medico-Marketing focusses on exchange of drug information among drug manufacturing company and the recommending doctor, Nurse, Pharmacist or with the end user. The intention behind this data exchange is to describe the Pharmaceutical Company’s products and how it will benefit the patient community in diagnosis or management of the human ailments.

Related Societies:

Societies in the USA: International Society for Computational Biology (ISCB) | American Medical Informatics Association | Bioinformatics.org | American association for the advancement of science | Boston Area Molecular Biology Computer Types (BAMBCT) | Great Lakes Bioinformatics Consortium(GLBC) | Midsouth Computational Biology And Bioinformatics Society (MCBIOS)

Societies in Europe: European Proteomics Association | Czech Free And Open Bioinformatic Association | European Molecular Biology Network |  Hellenic Society For Computational Biology And Bioinformatics | Bioinformatics Italian Society (BITS) | Netherlands Bioinformatics Center (NBIC).

Societies in Asia and Pacific: Bioinformatics society of India | Asia Pacific Bioinformatics Network | Australian Bioinformatics and Computational Biology Society (ABACBS) | Bioclues India, Japanese Society For Bioinformatics| Korean Society Of Bioinformatics (KSBi).

Track 17: Generics versus Big Pharma

Yet over the past decade in particular, most of the Big Pharma’s have adopted small molecule generics in one shape or form into their overall business model. And many of them openly talk about the “innovation headroom” that a healthy low-priced generics market enables i.e. the money saved on off-patent drugs can be used to fund high-priced new innovations. They have recognized that they cannot fight the realities of aging populations and healthcare economics.

Related Societies:

Societies in USA: American Society of Pharmacognosy (ASP) | Phytochemical Society of North America (PSNA) | The Herb Society of America | American Herbal Products Association (AHPA)

Societies in Europe: Phytochemical Society of Europe (PSE) | Society for Medicinal Plant and Natural Product Research | European Herbal and Traditional Medicines Association (EHTPA)

Societies in Asia and Pacific: The Asian Society of Pharmacognosy (ASP) | Society of Pharmacognosy, Malaysian Natural Product Society (MNPS) | The Japanese Society of Pharmacognosy | Australian Society of Plant Scientists

Track 18: Pharma and Biotech Financial Outlook

The downturn in the global economy has forced Pharmaceutical and life sciences companies to focus on cost-saving initiatives, putting stress on finance departments. Although optimizing costs will always be important, reinvigorating R&D will most likely be a top strategic initiative for these companies as well. Most big Pharmaceutical companies are under competitive pressure from generic drug makers pressure that will become more intense as an increasing number of patents for “blockbuster” drugs expire during the next few years.

Related Societies:

Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Market Analysis :

Glance at Market of Pharma Research and Development:

The United States is the world’s largest market for pharmaceuticals and the world leader in biopharmaceutical research.The global market for pharmaceutical Research was $70.1 billion in 2017 and $68.9 billion in 2019and this market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018 and the global advanced Pharma Research  market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.The major attraction includes Liberty Bell, Franklin Institute, Eastern State Penitentiary, Barnes Foundation and many more.

Active Pharmaceutical Ingredient Market:

Transparency Market research states the opportunity in this market will be worth US$219.60 bn by 2023 from US$134.7 bn in 2015. Between the forecast period of 2015 and 2023, the overall market is expected to expand at a CAGR of 6.3%. Between the forecast period of 2015 and 2023, the overall market is expected to expand at a CAGR of 6.3%.

Pharmaceutical Excipients:

The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021. The rising demand for new drug delivery systems, greater understanding of the functional benefits of excipients, growing pharmaceutical industry, and patent expiries of several blockbuster drugs are positively impacting the overall growth of the market.

Global Pharmaceutical excipients Market, by Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

China